Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$29.21 - $46.58 $14,605 - $23,290
-500 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$24.84 - $45.46 $12,420 - $22,730
500 New
500 $23,000
Q2 2019

Aug 14, 2019

SELL
$15.0 - $22.49 $15,000 - $22,490
-1,000 Closed
0 $0
Q4 2018

May 23, 2019

BUY
$10.95 - $15.44 $10,950 - $15,440
1,000 New
1,000 $15,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $856M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.